CClinicalTrials.gg
CompletedNCT03555331INSIGHTUpdated May 8, 2025

Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) - Long Term Follow-Up

An observational study in Child Obesity, sponsored by Milton S. Hershey Medical Center. Completed at 2 sites in United States. Per ClinicalTrials.gov, last updated 2025-05-08.

Sponsored by Milton S. Hershey Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
216
Sex
All
01

Study summary

Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT 2)-Long Term Follow-up will follow participants enrolled in the Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) (NCT01167270) study from age 3 years through the developmentally important time at school-entry around age 6 years and into middle childhood at age 9.

Read the detailed description

INSIGHT(NCT01167270) is a randomized, clinical trial evaluating a responsive parenting (RP) intervention designed to prevent rapid infant weight gain and childhood obesity among first-born infants. RP has been shown to promote a range of adaptive outcomes in children including secure attachment, cognitive development, and self-regulation of emotions and behavior with the potential for many beneficial effects including obesity prevention. INSIGHT's RP intervention is being compared with a home safety control intervention using a birth cohort of 279 infants and parents who received four home visits during the first year followed by annual clinic visits through age 3 years.

The study team will now follow the INSIGHT cohort with growth measurements from ages 5-9 years and with an in-depth assessment of parenting and child behaviors around the time of grade school entry at age 6. The study extension is observational and participants will not be given any further parenting or safety guidance as described in the initial grant.

02

Conditions studied

  • Child Obesity

Browse trials for

Keywords

  • responsive parenting
03

In context

Pediatric Obesity

1,117 studies on the registry are indexed under Pediatric Obesity; 189 are open to participants now.

This study's enrollment of 216 is close to the median of 200 across 231 observational studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Milton S. Hershey Medical Center is the lead sponsor of 480 studies on the registry; 61 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 42 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

INSIGHT had a birth cohort of 279 infants and parents. Participating dyads received four home visits during the first year followed by annual clinic visits through age 3 years. This study extension will include actively participating parents and children from this original birth cohort that are willing to continue to be followed by the study team.

Inclusion criteria

  • Participating in the INSIGHT study.

Exclusion criteria

Exclusion Criteria:

  • Unwilling to continue study participation for the study continuation.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
216 participants (actual)
Patient registry
No

Groups and cohorts

  • INSIGHT participants

    Mother-child dyads who enrolled in the INSIGHT Study and participated from early infancy to age 3 years will be followed through age 9 years.

    Behavioral: Child Safety Control Intervention · Behavioral: Responsive Parenting Intervention

Interventions

  • BehavioralChild Safety Control Intervention

    In the study period which spanned from early infancy through age 3 years, the child safety intervention group was given an educational program with messages focused on child and home safety, guided by the American Academy of Pediatrics and the Academy's guide for health supervision, Bright Futures. The observation-only study extension will not include any intervention, rather it will assess any long term outcomes from the education given to parents when their children were 0-2 years old.

  • BehavioralResponsive Parenting Intervention

    During infancy, the Responsive Parenting group was given an educational program containing messages providing developmentally appropriate guidance to parents of infants on responsive parenting and healthy lifestyle aimed at preventing rapid weight gain in infancy and overweight at age 3 years. The new study period will not include any intervention, rather it will assess any long term outcomes from the education given to parents when their children were 0-2 years old.

06

What researchers measure

Primary outcomes

  1. Efficacy of an early life responsive parenting (RP) intervention as demonstrated by a main effect for study group on BMI from ages 3 through 9 years

    Repeated measures ANOVA will be used to examine BMI change from ages 3 through 9 years, testing for persistence of the RP effect across time points, and also for an interaction between occasion and intervention group. Tests for an interaction between child sex and study group will be performed.

    Time frame: 6/2018 through 9/2024

Secondary outcomes

  1. Mean BMI z-score

    ANOVA at ages 5, 6, and 9 years.

    Time frame: 6/2018 through 9/2024

  2. Proportion in each group overweight (BMI >=85th percentile) or obese (BMI >=95th percentile)

    Logistic regression analysis will be used to examine the intervention effects on the overweight/obese outcomes at 5, 6, and 9 years.

    Time frame: 6/2018 through 9/2024

  3. Test the sustained efficacy and long-term effects of an early life responsive parenting (RP) across the study period

    Repeated measures ANOVA will be used to examine BMI change from ages 3-4 weeks through 9 years.

    Time frame: 6/2018 through 9/2024

07

Study locations

2 sites
  • Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033, United States
  • Penn State University
    State College, Pennsylvania 16802, United States
08

References and documents

Publications

  • Paul IM, Williams JS, Anzman-Frasca S, Beiler JS, Makova KD, Marini ME, Hess LB, Rzucidlo SE, Verdiglione N, Mindell JA, Birch LL. The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) study. BMC Pediatr. 2014 Jul 18;14:184. doi: 10.1186/1471-2431-14-184. PubMed 25037579 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03555331
Lead sponsor
Milton S. Hershey Medical Center
Collaborators
Penn State University, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University at Buffalo, University of Connecticut
Responsible party
Ian M. Paul, MD (Professor of Pediatrics and Public Health Sciences; Chief, Division of Academic General Pediatrics; Vice Chair of Faculty Affairs, Department of Pediatrics, Milton S. Hershey Medical Center) — Principal investigator
First posted
Jun 13, 2018
Start date
Jun 7, 2018
Primary completion
Nov 15, 2024
Completion
Nov 15, 2024
Last update
May 8, 2025

Study contacts

Ian M Paul, MD, MSc
principal investigator · Penn State Hershey Milton S Hershey Medical Center
Jennifer Savage, PhD
principal investigator · Penn State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion